Search

In 2011, a pilot study was undertaken to assess the public health benefit of molecular surveillance for gonorrhoea in 21 EU/EEA countries. A total of 1 066 isolates collected under the 2010 European gonococcal antimicrobial surveillance programme were typed and 406 sequence types identified, with considerable diversity among countries.

​This report presents the results of the 4th round of the Salmonella External Quality Assessment (EQA) scheme for typing of Salmonella enterica spp.

The aim of the technical consultation was to review ECDC’s molecular surveillance strategy with leading scientists in molecular epidemiology and public health microbiology.

This report describes many of the aspects that should be taken into account. It systematically covers the entire process from sample provision and sequencing to data analysis and collaboration with other organisations.

This report presents the results of the sixth round of the Salmonella External Quality Assessment (EQA) scheme for typing of Salmonella enterica spp. enterica (further EQA-6).

This document presents the recommended priority options and implementation processes for the medium-term integration of molecular typing into EU-level surveillance and epidemic preparedness.

This roadmap Version 2.1, 2016–19 presents the recommended priority list of pathogens/diseases and technical implementation options for the medium-term integration of molecular/genomic typing into EU-level surveillance and epidemic preparedness.

This document sets out ECDC's five year vision for using whole genome sequencing (WGS) technology within the context of its agreed strategy and roadmap for integrating typing data into EU level surveillance and cross-border outbreak assessment.

The surveillance of Neisseria gonorrhoeae antimicrobial susceptibility in the European Union/European Economic Area (EU/EEA) has been co-ordinated by the European Centre for Disease Prevention and Control (ECDC) since 2009.